Sort by
Refine Your Search
-
Programme (FHT1) at the Singapore-ETH Centre (SEC) (https://fht.ethz.ch) developed and piloted innovative upper limb rehabilitation technologies and evaluated them in clinical settings, both in hospital and
-
preclinical biodistribution, PET, and SPECT imaging studies in mouse models. Investigate pharmacokinetic and pharmacodynamic properties of novel radiolabeled compounds. Work in a interdisciplinary environment
-
sciences. NCCR Genesis does not aim to provide answers in all fields, but to drive innovative research and achieve decisive progress. Details on NCCR Genesis are available on its website https://nccr
-
Validate the developed methods in an industrial environment Profile Required experience CH/EU/EFTA citizenship or a valid Swiss work permit Master’s degree (ETH, university) in mechanical engineering
-
of Mechanical and Process Engineering (D-MAVT) of the ETH Zurich, in the Zentrum Campus in Zurich, Switzerland. D-MAVT (https://mavt.ethz.ch/) is an interdisciplinary department with focus areas in process
-
The position is hosted in the Department of Mechanical and Process Engineering (D-MAVT) of the ETH Zurich, in the Zentrum Campus in Zurich, Switzerland. D-MAVT (https://mavt.ethz.ch/) is an interdisciplinary
-
sciences. NCCR Genesis does not aim to provide answers in all fields, but to drive innovative research and achieve decisive progress. Further details on NCCR Genesis are available on its website https://nccr
-
a vendor-neutral ecosystem and contribute to building a highly reliable and efficient environment for scientific workloads. What you will do Automate infrastructure provisioning and operational
-
the fundamental principles of nature to innovative technologies for society. The Institute of Theoretical Physics (https://itp.phys.ethz.ch/), D-PHYS, ETH Zurich is seeking to hire a Coordinator who will lead the
-
drug delivery platform, published in Nature Communications (https://www.nature.com/articles/s41467-020-18059-7), that enables localized, hyper-efficient delivery of therapeutic compounds to specific